Jefferies downgraded The Clorox Company from Buy to Hold. The firm lowered its price target to $98 from $125.
Analysts cited soft market share trends and the appointment of a new CEO as primary concerns. Jefferies expects increased business reinvestment and a rebasing of financial expectations.
The firm predicts fiscal 2027 earnings guidance will fall below consensus estimates. These developments suggest a more challenging and prolonged recovery for the company.